Bioprocess Bags Market size was valued at USD 3.92 billion in 2024 and is expected to reach USD 31.55 billion by 2037, registering around 17.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of bioprocess bags is assessed at USD 4.47 billion.
The accelerated growth of the market can be predominantly influenced by the widespread adoption of single-use technologies within the biopharmaceutical industry since it improves flexibility and limits the prevalence of cross-contamination risk.
For instance, as per the prediction of the World Health Organization, in acute-care hospitals out of every 100 patients over 7 patients from high-income nations and 15 patients in low- and middle-income countries are set to be affected in hospitals by at least one healthcare-associated infection (HAI). Hence, the demand for bioprocess bags is surging.
Moreover, there has been growing advancement in technology which has further influenced the enhancement of bioprocess bags. Additionally, producers are introducing novel materials for bioprocess bags which are estimated to improve the strength, restivity, and flexibility of bogs. Hence, the bioprocess bags market revenue is predicted to rise.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
17.4% |
Base Year Market Size (2024) |
USD 3.92 billion |
Forecast Year Market Size (2037) |
USD 31.55 billion |
Regional Scope |
|
Type (Single-Use, Multi-Use)
The multi-use segment in the bioprocess bags market is estimated to gain the largest revenue share of 60% in the year 2037. The major factor to dominate the market expansion is that multi-use bioprocess bags provide a cost-effective solution over multiple production cycles. However, even though the initial investment for these bags might be high as compared to single-use counterparts, the ability to be reused through proper sterilization processes results in significant cost savings over time. Hence, this element is necessary for producers involved in high-volume and continuous production processes.
Furthermore, according to the study published in the International Journal of Pharmaceutics, the overall cost per unit of product for multi-use bioprocess bags, which includes the expenses related to sterilization and cleaning, is lower by about 40% in contrast to single-use bags over a 10-cycle period. As a result, this benefit is predicted to boost the attractiveness of multi-use solutions. Therefore, with the surge in segment growth, the bioprocess market is also predicted to grow over the coming years.
End User (Biopharmaceutical, Contract Manufacturing Organizations, Research Institutes)
The biopharmaceutical segment in the bioprocess bags market is expected to garner a significant share in the year 2037. This growth of the segment is predicted to be encouraged by the growing development of biopharmaceutical companies across the world. Furthermore, the adoption of AI is also surging in this region which is why the production of bioprocess bags is estimated to surge.
Another major factor could be the growing aging population. With the rise in age, the prevalence of disease also grows. Hence, this is further predicted to influence the segment growth additionally driving the bioprocess bags market revenue.
Moreover, the contract manufacturing organizations segment is also predicted to observe a surge on account of its growing adoption by organizations to focus on the growth of the business. Also, since raw material prices are growing, the dependence on contract manufacturing is also surging. As a result, the market growth for bioprocess bags is estimated to grow.
Our in-depth analysis of the global market includes the following segments:
Type |
|
End-User |
|
Product |
|
Application |
|
APAC Market Forecast
The bioprocess bags market in the Asia Pacific region is projected to hold the largest revenue share of 37% by the end of 2037. The growth of the market in this region is poised to be encouraged by a growing population. About 60 percent or 4.3 billion of the world’s population reside in the Asia Pacific region. Hence, this has also increased the prevalence of personalized medications. Consequently, the bioprocess bags market is also set to rise.
Moreover, the development of cities is also increasing in this region which is further demanding advanced healthcare infrastructure. Hence, this factor is also predicted to dominate the demand for bioprocess bags since it also plays a significant role in the aim of eradicating plastics.
North American Market Statistics
The bioprocess bags market in the North American region is also projected to have notable growth over the forecast period. The North American region is a global hub for advanced biopharmaceutical research and development. This growth is poised to be influenced by a rising sedentary lifestyle which is additionally encouraging the cases of diabetes.
This is because, diabetes patients require intake of insulin or other diabetes medications along with an insulin pump, routine blood sugar monitoring, and more which further requires packaging. Hence, the adoption of 2D process bags is predicted to rise. Consequently, the market is projected to grow in this region.
Author Credits: Rajrani Baghel
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?